-
- Purpose
- Leukotriene CysLT1 antagonist
- Purity
- >98 % (HPLC), NMR (Conforms)
- Chemical Name
- 1-[[[(1R)-1-[3-(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]-methyl]-cyclopropaneacetic acid, monosodium salt, Montelukast sodium, Montelukast monosodium salt, MK-0476, MK-476, KS-1087
- Formula
- C35H35ClNO3S • Na
- Solubility
- Soluble in DMSO (50 mg/ml), or water (30 mg/ml), or ethanol (60 mg/ml)
-
-
- Comment
-
Source: Synthetic. Appearance: Powder
- Restrictions
- For Research Use only
-
- Handling Advice
- Classification: D2A Very Toxic Material Causing Other Toxic Effects - Reproductive hazard E Corrosive Material - Corrosive to skin Hazard statement(s): H318 Causes serious eye damage. H361fd Suspected of damaging fertility. Suspected of damaging the unborn child. Precautionary statement(s): P280 Wear protective gloves/ eye protection/ face protection. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
- Storage
- -20 °C
-
- Molecular Weight
- 608.2
- CAS-No
- 151767-02-1
-
You are here:
